{
  "query_id": "857",
  "timestamp": "2025-10-22T16:24:25.250562",
  "model": "Presidio-2.2.360",
  "query_type": "NEGATIVE (No PHI)",
  "analyzer_config": {
    "language": "en",
    "score_threshold": 0.35,
    "custom_recognizers": [
      "MedicalRecordNumberRecognizer",
      "UniqueIdentifierRecognizer"
    ]
  },
  "original_query": "Effectiveness of Dapagliflozin vs. Empagliflozin in reducing cardiovascular outcomes in patients with Type 2 Diabetes diagnosed in 2019?",
  "presidio_output": "Effectiveness of [REDACTED_NAME] vs. [REDACTED_NAME] in reducing cardiovascular outcomes in patients with Type 2 Diabetes diagnosed in [REDACTED_DATE]?",
  "presidio_entities_detected": [
    {
      "entity_type": "PERSON",
      "hipaa_category": "NAME",
      "start": 17,
      "end": 30,
      "score": 0.85,
      "text": "Dapagliflozin",
      "recognizer": "SpacyRecognizer"
    },
    {
      "entity_type": "PERSON",
      "hipaa_category": "NAME",
      "start": 35,
      "end": 48,
      "score": 0.85,
      "text": "Empagliflozin",
      "recognizer": "SpacyRecognizer"
    },
    {
      "entity_type": "DATE_TIME",
      "hipaa_category": "DATE",
      "start": 131,
      "end": 135,
      "score": 0.85,
      "text": "2019",
      "recognizer": "SpacyRecognizer"
    }
  ],
  "false_redaction_check": {
    "has_false_redactions": true,
    "redaction_count": 3,
    "false_redactions_by_type": {
      "NAME": 2,
      "DATE": 1
    },
    "status": "OVER_REDACTED"
  }
}